CellSight Technologies

CellSight Develops Positron Emission Tomography (PET) Tracers for the Development and Monitoring of Immuno-Oncology Therapies. Its PET Tracer Products Provide Clinicians with Imaging Tools to Evaluate Immunotherapy Responses Early in the Treatment Cycle, Enabling Informed Decision-Making.